688617.SS

APT Medical Inc. 688617.SS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 688617.SS 300832.SZ 300759.SZ 603087.SS 002252.SZ 300003.SZ 688578.SS 600085.SS 002223.SZ 600332.SS
6M 6.68 % 19.05 % 36.43 % 60.97 % -2.49 % 63.11 % 21.30 % -5.79 % 8.11 % -2.29 %
YTD 26.96 % -8.00 % 21.41 % 64.98 % -7.62 % 62.66 % 74.58 % -13.98 % 2.72 % -6.97 %
1Y 25.48 % -9.36 % 7.99 % 40.69 % -6.84 % 45.69 % 86.72 % -13.26 % 4.71 % -10.67 %
3Y 102.89 % 2.85 % -17.27 % 96.80 % 20.40 % -28.99 % 357.10 % -32.94 % 22.17 % -5.39 %
5Y 79.65 % -39.01 % -36.96 % -46.24 % -27.10 % -43.54 % 168.09 % 25.77 % 12.32 % -20.24 %
10Y 79.65 % 156.37 % 523.67 % 6.82 % -71.48 % -5.14 % 168.09 % 31.71 % 49.17 % -9.76 %
From the beginning 79.65 % 156.37 % 523.67 % 6.82 % 254.79 % 11.86 % 168.09 % 1 260.80 % 2 006.32 % 405.13 %

Dividend

APT Medical Inc.

Shenzhen New Industries Biomedical Engineering Co., Ltd.

Pharmaron Beijing Co., Ltd.

Gan & Lee Pharmaceuticals.

Shanghai RAAS Blood Products Co., Ltd.

Lepu Medical Technology (Beijing) Co., Ltd.

Shanghai Allist Pharmaceuticals Co., Ltd.

Beijing Tongrentang Co., Ltd

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited